The End of Compounded Tirzepatide: What You Need to Know

Understanding the FDA’s Recent Policy Clarification

The FDA recently clarified policies regarding compounded medications as the national supply of GLP-1 receptor agonists, including tirzepatide, begins to stabilize. These changes stem from the agency’s effort to ensure patient safety and regulate compounding practices. Read the full FDA statement here.

Tirzepatide, commonly compounded for weight loss during its drug shortage, is no longer on the FDA’s drug shortage list. View the FDA’s drug shortage resolution notice here. This change means compounded tirzepatide will be phased out in compliance with federal guidelines.

Black Friday Pricing Extension for Compounded Tirzepatide

To assist our clients in transitioning to FDA-approved options, we have extended our Black Friday pricing for compounded tirzepatide until February 18, 2025. Take advantage of these savings to complete your weight loss journey:

• Tirzepatide Starter Package (2.5mg/5.0mg/7.5mg): $799
• Tirzepatide 5mg (90 Day Supply): $848 (Regular $1247, Save $399)
• Tirzepatide 7.5mg (90 Day Supply): $1098 (Regular $1397, Save $299)
• Tirzepatide 10mg (90 Day Supply): $1148 (Regular $1547, Save $399)
• Tirzepatide 12.5mg (90 Day Supply): $1398 (Regular $1697, Save $299)
• Tirzepatide 15mg (90 Day Supply): $1448 (Regular $1847, Save $399)

This pricing is designed to help clients who are transitioning from compounded to FDA-approved medications or other alternatives.

Exploring FDA-Approved Alternatives

As compounded tirzepatide becomes unavailable, FDA-approved alternatives are becoming more accessible. Medications like Wegovy (semaglutide) and Mounjaro (tirzepatide) are now in stable supply. These options provide consistent dosing, safety, and efficacy that meet FDA standards.

Benefits of FDA-Approved Medications

• Regulated manufacturing processes
• Clinically tested and proven efficacy
• Reliable supply chain and dosage standardization

Our team is here to guide you through the transition process and help you understand insurance coverage and affordability options for these medications.

Oral Weight Loss Medication Options

If you’re on compounded tirzepatide, don’t worry—we have options to keep your weight loss journey on track:

• Zepbound™ Vials: Available directly through Eli Lilly for 2.5mg and 5mg doses. Our visits for Zepbound™ prescriptions are just $60. Learn more about Zepbound™ here.
• Oral Medications: Great alternatives for those who prefer non-injectable options. Explore medications like:
  • Qsymia®
  • Contrave®
  • Adipex
  • Lomaira®

Our team is here to guide you in selecting the best medication for your needs and preferences. Whether you prefer injectables like Zepbound™ or oral alternatives, we’re committed to supporting your weight loss journey.

What This Means for Current Clients

If you’re currently using compounded tirzepatide, it’s important to plan for your transition now. Our extended Black Friday pricing provides an opportunity to stock up while you explore FDA-approved or oral alternatives.

We encourage clients to schedule a consultation to discuss their options, including insurance coverage and pricing for approved medications. We are committed to ensuring a smooth transition that minimizes any disruption to your weight loss progress.

Planning Your Next Steps

The end of compounded tirzepatide marks a significant shift in weight loss medication options, but it also opens the door to safer and more regulated alternatives. Take advantage of our extended pricing to transition seamlessly and explore FDA-approved and oral options tailored to your needs.

Contact our team today to learn more about your options and how we can support your weight loss journey.